首页> 美国卫生研究院文献>PLoS Clinical Trials >Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening
【2h】

Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening

机译:F8,F9和VWF的靶向重测序:离子激流数据的表征及其对突变筛查的临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations are not identified in ~5% of hemophilia A and 10–35% of type 1 VWD patients. The bleeding tendency also varies among patients carrying the same causative mutation, potentially indicating variants in additional genes modifying the phenotype that cannot be identified by routine single-gene analysis. The F8, F9 and VWF genes were analyzed in parallel using an AmpliSeq strategy and Ion Torrent sequencing. Targeting all exonic positions showed an average read depth of >2000X and coverage close to 100% in 24 male patients with known disease-causing mutations. Discrimination between reference alleles and alternative/indel alleles was adequate at a 25% frequency threshold. In F8, F9 and VWF there was an absolute majority of all reference alleles at allele frequencies >95% and the average alternative allele and indel frequencies never reached above 10% and 15%, respectively. In VWF, 4–5 regions showed lower reference allele frequencies; in two regions covered by the pseudogene close to the 25% cut-off for reference alleles. All known mutations, including indels, gross deletions and substitutions, were identified. Additional VWF variants were identified in three hemophilia patients. The presence of additional mutations in 2 out of 16 (12%) randomly selected hemophilia patients indicates a potential mutational contribution that may affect the disease phenotype and counseling in these patients. Parallel identification of disease-causing mutations in all three genes not only confirms the deficiency, but differentiates phenotypic overlaps and allows for correct genetic counseling.
机译:约5%的血友病A和10–35%的1型VWD患者未发现突变。携带相同病因突变的患者的出血趋势也有所不同,这可能表明修饰表型的其他基因的变异无法通过常规单基因分析来鉴定。使用AmpliSeq策略和Ion Torrent测序并行分析F8,F9和VWF基因。针对所有外显子位置,显示24名具有已知致病突变的男性患者的平均读取深度> 2000X,覆盖率接近100%。在25%的频率阈值下,参考等位基因与替代/插入/缺失等位基因之间的区分是足够的。在F8,F9和VWF中,等位基因频率> 95%时,绝对是所有参考等位基因的绝大部分,平均替代等位基因和插入缺失频率分别从未达到10%和15%以上。在VWF中,4–5个区域显示较低的参考等位基因频率。在假基因覆盖的两个区域中,参考等位基因的截止频率接近25%。鉴定了所有已知的突变,包括插入缺失,总体缺失和取代。在三名血友病患者中发现了其他VWF变异体。在随机选择的16名血友病患者中,有2名(12%)存在额外的突变,表明潜在的突变贡献可能会影响这些患者的疾病表型和咨询。对所有三个基因中致病突变的平行鉴定不仅证实了缺陷,而且区分了表型重叠,并提供了正确的遗传咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号